Advertisement
Canada markets open in 1 hour 11 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7270
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    82.15
    -0.58 (-0.70%)
     

  • Bitcoin CAD

    89,852.48
    +3,917.34 (+4.56%)
     

  • CMC Crypto 200

    1,336.96
    +24.34 (+1.89%)
     

  • GOLD FUTURES

    2,391.80
    -6.20 (-0.26%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,489.50
    -57.75 (-0.33%)
     

  • VOLATILITY

    18.78
    +0.78 (+4.33%)
     

  • FTSE

    7,834.40
    -42.65 (-0.54%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6818
    -0.0003 (-0.04%)
     

Stocks in play: BriaCell Therapeutics Corp.

Baystreet.ca

Announced that the U.S. Food and Drug Administration has granted Fast Track status to BriaCell’s lead candidate, Bria-IMT™, for the treatment of metastatic breast cancer (breast cancer that has spread beyond the breast). The Fast Track designation will apply to patients with metastatic breast cancer. BriaCell is developing Bria-IMT™ in combination with immune checkpoint inhibitors in a clinical trial. BriaCell Therapeutics Corp. shares T.BCT are trading up $0.57 at $13.07.

Read: